vs

Side-by-side financial comparison of Crexendo, Inc. (CXDO) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

Crexendo, Inc. is the larger business by last-quarter revenue ($18.1M vs $14.7M, roughly 1.2× IRIDEX CORP). On growth, Crexendo, Inc. posted the faster year-over-year revenue change (11.2% vs -69.7%). Over the past eight quarters, Crexendo, Inc.'s revenue compounded faster (12.4% CAGR vs 11.9%).

Crexendo, Inc. is a U.S.-headquartered cloud communications technology provider. It delivers unified communications as a service (UCaaS), contact center solutions, business VoIP services, and collaborative work tools, primarily catering to small and medium-sized enterprises operating in the North American market.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

CXDO vs IRIX — Head-to-Head

Bigger by revenue
CXDO
CXDO
1.2× larger
CXDO
$18.1M
$14.7M
IRIX
Growing faster (revenue YoY)
CXDO
CXDO
+81.0% gap
CXDO
11.2%
-69.7%
IRIX
Faster 2-yr revenue CAGR
CXDO
CXDO
Annualised
CXDO
12.4%
11.9%
IRIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CXDO
CXDO
IRIX
IRIX
Revenue
$18.1M
$14.7M
Net Profit
$1.2M
Gross Margin
37.2%
Operating Margin
6.3%
Net Margin
6.7%
Revenue YoY
11.2%
-69.7%
Net Profit YoY
140.2%
EPS (diluted)
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CXDO
CXDO
IRIX
IRIX
Q4 25
$18.1M
$14.7M
Q3 25
$17.5M
$12.5M
Q2 25
$16.6M
$13.6M
Q1 25
$16.1M
$11.9M
Q4 24
$16.2M
$12.7M
Q3 24
$15.6M
$11.6M
Q2 24
$14.7M
$12.6M
Q1 24
$14.3M
$11.8M
Net Profit
CXDO
CXDO
IRIX
IRIX
Q4 25
$1.2M
Q3 25
$1.4M
$-1.6M
Q2 25
$1.2M
$-994.0K
Q1 25
$1.2M
$-1.7M
Q4 24
$507.0K
$-834.0K
Q3 24
$148.0K
$-1.9M
Q2 24
$588.0K
$-2.7M
Q1 24
$434.0K
$-3.5M
Gross Margin
CXDO
CXDO
IRIX
IRIX
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
CXDO
CXDO
IRIX
IRIX
Q4 25
6.3%
Q3 25
7.5%
-11.3%
Q2 25
6.7%
-6.9%
Q1 25
7.2%
-1.7%
Q4 24
3.9%
-3.9%
Q3 24
0.9%
-16.1%
Q2 24
3.9%
-20.9%
Q1 24
3.4%
-28.0%
Net Margin
CXDO
CXDO
IRIX
IRIX
Q4 25
6.7%
Q3 25
8.3%
-12.6%
Q2 25
7.4%
-7.3%
Q1 25
7.3%
-14.2%
Q4 24
3.1%
-6.6%
Q3 24
0.9%
-16.7%
Q2 24
4.0%
-21.2%
Q1 24
3.0%
-29.5%
EPS (diluted)
CXDO
CXDO
IRIX
IRIX
Q4 25
$0.03
Q3 25
$0.05
$-0.09
Q2 25
$0.04
$-0.06
Q1 25
$0.04
$-0.10
Q4 24
$0.03
$-0.05
Q3 24
$0.00
$-0.12
Q2 24
$0.02
$-0.16
Q1 24
$0.01
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CXDO
CXDO
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$6.0M
Total DebtLower is stronger
$114.0K
Stockholders' EquityBook value
$63.8M
Total Assets
$77.7M
$29.2M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CXDO
CXDO
IRIX
IRIX
Q4 25
$6.0M
Q3 25
$5.6M
Q2 25
$6.8M
Q1 25
$7.2M
Q4 24
$2.4M
Q3 24
$3.9M
Q2 24
$4.1M
Q1 24
$5.4M
Total Debt
CXDO
CXDO
IRIX
IRIX
Q4 25
$114.0K
Q3 25
$236.0K
Q2 25
$356.0K
Q1 25
$475.0K
Q4 24
$592.0K
$1.0M
Q3 24
$709.0K
$1.4M
Q2 24
$823.0K
Q1 24
$937.0K
Stockholders' Equity
CXDO
CXDO
IRIX
IRIX
Q4 25
$63.8M
Q3 25
$61.3M
$4.7M
Q2 25
$58.3M
$6.1M
Q1 25
$55.2M
$852.0K
Q4 24
$51.4M
$2.1M
Q3 24
$49.5M
$2.6M
Q2 24
$48.2M
$4.2M
Q1 24
$46.8M
$6.5M
Total Assets
CXDO
CXDO
IRIX
IRIX
Q4 25
$77.7M
$29.2M
Q3 25
$76.0M
$28.4M
Q2 25
$71.4M
$31.6M
Q1 25
$67.4M
$34.2M
Q4 24
$64.9M
$29.1M
Q3 24
$62.3M
$30.2M
Q2 24
$59.6M
$31.2M
Q1 24
$57.5M
$34.1M
Debt / Equity
CXDO
CXDO
IRIX
IRIX
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.01×
Q1 25
0.01×
Q4 24
0.01×
0.48×
Q3 24
0.01×
0.53×
Q2 24
0.02×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CXDO
CXDO
IRIX
IRIX
Operating Cash FlowLast quarter
$2.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CXDO
CXDO
IRIX
IRIX
Q4 25
$2.3M
Q3 25
$4.4M
$-1.2M
Q2 25
$1.3M
$-397.0K
Q1 25
$1.2M
$-1.1M
Q4 24
$2.2M
$-1.2M
Q3 24
$1.6M
$-3.1M
Q2 24
$2.7M
$-1.3M
Q1 24
$-166.0K
$-1.6M
Free Cash Flow
CXDO
CXDO
IRIX
IRIX
Q4 25
Q3 25
$-1.2M
Q2 25
$1.3M
$-410.0K
Q1 25
$-1.2M
Q4 24
$2.1M
$-1.2M
Q3 24
$-3.1M
Q2 24
Q1 24
$-1.7M
FCF Margin
CXDO
CXDO
IRIX
IRIX
Q4 25
Q3 25
-9.4%
Q2 25
7.7%
-3.0%
Q1 25
-9.8%
Q4 24
13.2%
-9.8%
Q3 24
-26.5%
Q2 24
Q1 24
-14.0%
Capex Intensity
CXDO
CXDO
IRIX
IRIX
Q4 25
0.0%
Q3 25
0.0%
0.1%
Q2 25
0.1%
0.1%
Q1 25
0.0%
0.1%
Q4 24
0.2%
0.1%
Q3 24
0.0%
0.0%
Q2 24
0.0%
0.0%
Q1 24
0.0%
0.0%
Cash Conversion
CXDO
CXDO
IRIX
IRIX
Q4 25
1.93×
Q3 25
3.05×
Q2 25
1.05×
Q1 25
1.06×
Q4 24
4.29×
Q3 24
10.95×
Q2 24
4.51×
Q1 24
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CXDO
CXDO

Services$8.6M48%
Software Solution Segment$8.3M46%
Products$1.1M6%

IRIX
IRIX

Segment breakdown not available.

Related Comparisons